Articles about 'Department of Clinical Neurosciences'

Research raises possibility of devices in the future to help some patients in a vegetative state interact with the outside world.

Critical insight provided into the disease mechanisms behind multiple sclerosis.

The British Academy has today announced the scholars elected for this year’s Fellowships in recognition of their contribution to the humanities and social sciences.

A major new drive to understand, diagnose and treat Alzheimer’s disease has begun in Cambridge.

The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.

Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.